ENO3 and Duchenne muscular dystrophy: Within the DMD patient group, besides CA3, ETFA, MDH2, and MYL3, two other proteins, TNNT3 and ENO3, revealed significantly different profiles between the ambulant and non-ambulant DMD patients.